Atovaquone Nanosuspensions Show Excellent Therapeutic Effect in a New Murine Model of Reactivated Toxoplasmosis

Immunocompromised patients are at risk of developing toxoplasma encephalitis (TE). Standard therapy regimens (including sulfadiazine plus pyrimethamine) are hampered by severe side effects. While atovaquone has potent in vitro activity against Toxoplasma gondii, it is poorly absorbed after oral admi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schöler, Nadja, Krause, Karsten, Kayser, Oliver, Müller, Rainer H., Borner, Klaus, Hahn, Helmut, Liesenfeld, Oliver
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2001
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC90544/
https://ncbi.nlm.nih.gov/pubmed/11353624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.6.1771-1779.2001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados